Rs
Regulatory Strategy
007 Regulatory Strategy
The ValSource regulatory consulting team brings more than 50 years of combined experience at the U.S. FDA and has provided scientific and regulatory guidance for thousands of pharmaceutical, biopharmaceutical, and combination products. We deliver practical, science- and risk-based regulatory support throughout the product lifecycle, helping clients prepare for inspections, respond to regulatory observations, develop defensible validation and submission strategies, and implement effective remediation plans.
Our consultants are recognized industry leaders who have contributed to FDA guidance documents, provided input on national and international standards, and supported the development of industry technical reports. Our expertise spans small and large molecules, drug-device and biologic-device combination products, and radiopharmaceuticals from first-in-human development through post-commercialization. We also help clients navigate complex regulatory interactions by developing effective communication strategies for marketing applications, compliance responses, and technical requests.
007 Regulatory Strategy services
Vd
Validation Design & Execution
- Validation strategy
- Aseptic/sterile readiness
- Post-approval changes
Rs
Regulatory Strategy & Submissions
- IND, BLA, NDA, DMF, PMA
- Marketing authorization
- Lifecycle management
Rr
Remediation & Compliance Recovery
- 483/Warning letter response
- remediation roadmap
- effectiveness checks
Ir
Inspection Readiness & Correspondence
ValSource consultants have decades of experience at the U.S. Food and Drug Administration (FDA) and are uniquely qualified to provide practical recommendations that drive inspection readiness.
- mock audits
- validation package review
- Deviation and CAPA review
- SME coaching and interview prep
- written gap assessment report
- prioritized remediation roadmap
- inspection readiness action plan
- effectiveness check strategy
- executive summary/decision support